ATE154605T1 - Ungesättigte phosphonat-derivate von purinen und pyrimidinen - Google Patents

Ungesättigte phosphonat-derivate von purinen und pyrimidinen

Info

Publication number
ATE154605T1
ATE154605T1 AT94912742T AT94912742T ATE154605T1 AT E154605 T1 ATE154605 T1 AT E154605T1 AT 94912742 T AT94912742 T AT 94912742T AT 94912742 T AT94912742 T AT 94912742T AT E154605 T1 ATE154605 T1 AT E154605T1
Authority
AT
Austria
Prior art keywords
pyrimidines
purines
phosphonate derivatives
unsaturated phosphonate
antiviral agents
Prior art date
Application number
AT94912742T
Other languages
English (en)
Inventor
Patrick Casara
Jean-Francoise Nave
Serge Halazy
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE154605T1 publication Critical patent/ATE154605T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Saccharide Compounds (AREA)
AT94912742T 1993-04-01 1994-02-25 Ungesättigte phosphonat-derivate von purinen und pyrimidinen ATE154605T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400842A EP0618214A1 (de) 1993-04-01 1993-04-01 Ungesättigte Phosphonatderivate Purinen und Pyrimidinen
PCT/US1994/001837 WO1994022882A1 (en) 1993-04-01 1994-02-25 Unsaturated phosphonates derivatives of purines and pyrimidines

Publications (1)

Publication Number Publication Date
ATE154605T1 true ATE154605T1 (de) 1997-07-15

Family

ID=8214695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912742T ATE154605T1 (de) 1993-04-01 1994-02-25 Ungesättigte phosphonat-derivate von purinen und pyrimidinen

Country Status (17)

Country Link
EP (2) EP0618214A1 (de)
JP (1) JPH08508481A (de)
CN (2) CN1046288C (de)
AT (1) ATE154605T1 (de)
AU (1) AU681395B2 (de)
CA (1) CA2159451C (de)
DE (1) DE69403910T2 (de)
DK (1) DK0701562T3 (de)
ES (1) ES2105684T3 (de)
FI (1) FI113539B (de)
GR (1) GR3024788T3 (de)
HU (1) HUT72459A (de)
IL (1) IL109152A0 (de)
NO (1) NO953878L (de)
NZ (1) NZ263904A (de)
WO (1) WO1994022882A1 (de)
ZA (1) ZA942092B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
TW369536B (en) * 1996-01-18 1999-09-11 Mitsubishi Chem Corp Phosphonate nucleotide compounds
FR2781229B1 (fr) * 1998-07-17 2001-11-30 Univ Nice Sophia Antipolis Nouveaux composes analogues des nucleotides, leurs procedes de preparation et leurs applications
GB9821058D0 (en) 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
KR100891366B1 (ko) 2001-06-29 2009-04-02 인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 항 바이러스 활성을 갖는 6-'2-(포스포노메톡시)알콕시 피리미딘 유도체
JP2005508924A (ja) * 2001-08-30 2005-04-07 三菱ウェルファーマ株式会社 抗ウイルス剤
DK1644389T3 (da) 2003-06-16 2011-05-09 Acad Of Science Czech Republic Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
US7579332B2 (en) 2003-07-30 2009-08-25 Gilead Sciences, Inc. Nucleobase phosphonate analogs for antiviral treatment
EP1866319B1 (de) * 2005-04-01 2011-11-23 The Regents of The University of California Phosphono-pent-2-en-1-yl-nukleoside und analoga
WO2006114064A2 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
CN100352823C (zh) * 2005-08-19 2007-12-05 浙江车头制药有限公司 一种腺嘌呤衍生物的制备方法
WO2008100447A2 (en) 2007-02-09 2008-08-21 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
DK2794624T3 (da) 2011-12-22 2019-07-22 Geron Corp Guanin-analoger som telomerase-substrater og påvirkere af telomer-længde
CN117482102A (zh) 2016-02-18 2024-02-02 伊维萨股份有限公司 使用5′-腺苷二磷酸核糖(adpr)的方法
WO2019191026A2 (en) 2018-03-27 2019-10-03 Invirsa, Inc. Methods for the use of 5'-adenosine diphosphate ribose (adpr)
CN108383872B (zh) * 2018-04-18 2019-07-12 南京师范大学 一种-1,1-二氟-3-磺酰基-2,4-戊二烯膦酸酯类化合物及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017054C (en) * 1990-05-16 1999-08-10 Jack S. Wilson Automatic storage and retrieval system
HU9300132D0 (en) * 1990-07-19 1993-04-28 Beecham Group Plc Method for producing phosphono-alkene-purine derivatives and medical preparatives of anti-viral effect containing them
EP0531597A1 (de) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Ungesättigte azyklische Phosphonsäure Purinderivats und Pyrimidinderivate
KR0184530B1 (ko) * 1991-10-11 1999-05-15 카렐 마르티넥 항비루스 비고리 포스포노메톡시알킬치환, 알켄일 및 알킨일 퓨린 및 피리미딘 유도체

Also Published As

Publication number Publication date
CA2159451C (en) 1999-04-13
WO1994022882A1 (en) 1994-10-13
GR3024788T3 (en) 1998-01-30
IL109152A0 (en) 1994-06-24
FI113539B (fi) 2004-05-14
EP0618214A1 (de) 1994-10-05
CN1229084A (zh) 1999-09-22
ES2105684T3 (es) 1997-10-16
DK0701562T3 (da) 1997-07-07
ZA942092B (en) 1994-10-24
EP0701562A1 (de) 1996-03-20
CA2159451A1 (en) 1994-10-13
FI954615A0 (fi) 1995-09-28
JPH08508481A (ja) 1996-09-10
DE69403910D1 (de) 1997-07-24
NZ263904A (en) 1996-11-26
CN1120338A (zh) 1996-04-10
AU6516294A (en) 1994-10-24
HU9502854D0 (en) 1995-11-28
CN1046288C (zh) 1999-11-10
DE69403910T2 (de) 1998-01-29
NO953878D0 (no) 1995-09-29
AU681395B2 (en) 1997-08-28
HUT72459A (en) 1996-04-29
FI954615A (fi) 1995-09-28
NO953878L (no) 1995-12-01
EP0701562B1 (de) 1997-06-18

Similar Documents

Publication Publication Date Title
ATE154605T1 (de) Ungesättigte phosphonat-derivate von purinen und pyrimidinen
ATE126232T1 (de) Neue derivate von a-nor-3-carboxysteroiden.
ES2148486T3 (es) Intermediarios de cloropirimidina.
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
DE69110854D1 (de) Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin.
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
ZA913033B (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use
FI924424A (fi) Hjaertskyddande tokoferolanaloger
DE68927651T2 (de) Derivate von Fluorphosphonat-Nukleotiden
DE69927251D1 (de) Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
DE68928752T2 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
ES2089159T3 (es) Nuevos derivados de acido ascorbico.
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
DE69418050T2 (de) Antivirale analoge von difluorostaton
ES2168269T3 (es) Intermedios y procedimientos para los mismos, para la preparacion de 5,6-dihidropirrolo(2,3-d)pirimidina.
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee